Transforming Large B-Cell Lymphoma (LBCL): CAR T and Novel Agents

Experts explore the transformative impact of CAR T-cell therapy on lymphoma treatment, covering mechanisms of action, first-line applications, and ongoing challenges.

EP. 1: Understanding LBCL: Presentation, Diagnosis, and Prognostic Indicators

November 22nd 2023

Explore the diverse ways large B-cell lymphoma can manifest, the diagnostic process, and prognostic indicators for effective management.

EP. 2: Large B-Cell Lymphoma: Treatment Approaches and Evolving Therapies

November 22nd 2023

Expert insight into current treatment strategies and emerging therapies for diffuse large B-cell lymphoma, a challenging malignancy.

EP. 3: Advancing Lymphoma Treatments: CAR T-Cell and Bispecific Therapies

November 28th 2023

Discover cutting-edge cellular therapeutics, CAR T-cell therapy, and bispecific strategies for treating lymphoma patients in clinical trials.

EP. 4: CAR T-Cell Therapy’s Impact on Lymphoma Management

November 28th 2023

Gain insights into CAR T-cell therapy's impact on lymphoma treatment through a historical perspective and mechanism of action.

EP. 5: Real-World Use of CAR T-Cell Therapy in Patients with Lymphoma

December 5th 2023

Explore the real-world application of CAR T-cell therapy in lymphoma treatment, from response rates to its role in first-line therapy.

EP. 6: Challenges in CAR T-Cell Therapy for Lymphoma

December 5th 2023

Delve into the challenges of CAR T-cell therapy access and explore the biology behind treatment responses and relapses in lymphoma patients.

EP. 7: Exploring LBCL: Transplant Eligibility and Second Line Treatment Selection of Novel Agents

December 5th 2023

Fred Locke, MD, provides an overview of transplant eligibility for patients with large B-cell lymphoma, highlighting second line strategies with CAR T-cell therapy and bispecific antibodies.

EP. 8: CAR T: A Review of Clinical Data for Second Line Treatments of Large B-Cell Lymphoma

December 5th 2023

Dr. Locke reviews the latest data from ZUMA-7 and TRANSFORM studies, evaluating CAR T in the second line setting for R/R LBCL.

EP. 9: Approaches to Treatment Sequencing in LBCL

December 12th 2023

Expert perspective on treatment sequencing strategies for patients with LBCL.

EP. 10: Innovations in Immunotherapy: CAR T-Cells, Allogeneic Approaches, and Bispecifics

December 12th 2023

Expert perspective on advancements in cancer immunotherapy, including CAR-T cells, allogeneic strategies, and the role of bispecific antibodies.